SAM
EXAS

Solaris Asset Management’s Exact Sciences EXAS Stock Holding History

Solaris Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,785
Closed -$94K – 93
2017
Q4 		$94K Hold
1,785
– – 0.05% 132
2017
Q3 		$84K Buy
+1,785
New +$71.9K 0.05% 137

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Solaris Asset Management's EXAS Position: Q1 2018 in Review

Solaris Asset Management sold out of Exact Sciences (EXAS) in Q1 2018, closing a stake of 1,785 shares — an estimated $94K sold.

Solaris Asset Management first reported a position in EXAS in Q3 2017 and held it in 2 quarters. The position peaked at $94K in Q4 2017. 319 funds tracked by Wall St. Rank hold EXAS as of Q1 2018.

  • Solaris Asset Management reported no remaining Exact Sciences position as of Q1 2018 after selling out during the quarter.
  • Solaris Asset Management sold 1,785 Exact Sciences shares in Q1 2018, an estimated $94K.
  • Solaris Asset Management first reported a position in Exact Sciences in Q3 2017 and held it in 2 quarters.
  • Solaris Asset Management's Exact Sciences position peaked at $94K in Q4 2017.
  • 319 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2018.

Based on Solaris Asset Management's 13F filing for Q1 2018, filed 16 Apr 2018.